Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NNFA GMP meeting

This article was originally published in The Tan Sheet

Executive Summary

The National Nutritional Foods Association recently met with the Office of Management & Budget to discuss the forthcoming good manufacturing practices for dietary supplements, NNFA CEO David Seckman says. The trade group set up the meeting to "represent the association's interests" as well as stress the importance of "expediting the review process," Seckman explained. NNFA reiterated views previously expressed to FDA about important aspects of the proposed rule such as expiration dating for dietary supplements, he adds. OMB did not indicate when the final rule will be released. GMPs were received by OMB on Oct. 25; the Executive Branch office has a 90-day period to review the final rule before sending it back to FDA for publication (1"The Tan Sheet" Oct. 31, 2005, p. 9)...

You may also be interested in...



Supplement GMPs Received By OMB For 90-Day Clearance Review

FDA's goal of issuing a final rule on dietary supplement current Good Manufacturing Practices by the end of the year may be within reach

UCB And Microsoft Expand AI Tie-Up Beyond COVID-19

Two European pharmaceutical companies, UCB and Merck KGaA, are exploring artificial intelligence in different ways, the first for drug discovery and the second on a fundamental level.

UK: Commercial Framework Sheds Light On Working With NHS And NICE

The final text brings some changes, including the introduction of an escalation process when companies and NHS England cannot agree.

Topics

UsernamePublicRestriction

Register

LL1132098

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel